EAA173: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma
- Title
- Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma
- Principal Investigator
- Veltri, Lauren
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Wheeling Hospital
- Contacts
- Maher Kali, MD
- Clinical Research Specialist-WVUCI
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org
- Kathryn Oliverio, LPN
- Research Specialist
- Phone: +1 304-293-7374
- Email: kathryn.oliverio1@hsc.wvu.edu